MOKA TECH

Our Technology

The specialized intelligence layer of Latin American biodiversity.

Analytical thinking

Experimental lobe

AI model trained on in-house experimental data

Creative thinking

In silico lobe

AI model trained on in-house predicted data

HOW IT WORKS

MokaDex integrates nature’s knowledge with cutting edge technology

MokaDex combines empirical evidence with predictive biology to turn Latin America's biodiversity into a searchable, programmable discovery system.

Left Brain

Empirical data — chemical fingerprints, LC-MS, experimental bioactives, species records, and validated biological activity.

Right Brain

MokaDex — bioinformatic prediction, mechanism of action inference, structure-activity relationships, pathway mapping, and market intelligence.

Together

A knowledge graph of Latin American biodiversity — built to identify what nature already knows, and translate it into molecules, products, IP, and scalable innovation.

RAW DATA

Botanical & Scientific Data

Botanical literature, phytochemistry references, species records, and experimental datasets structured for MokaDex analysis.

INTELLIGENCE

AI / Knowledge Graph

MokaDex connects species, compounds, evidence, and biological signals through graph-based reasoning.

VALIDATED

Bioactivity Intelligence

MokaDex helps prioritize mechanism hypotheses, biological targets, and bioactivity signals for further validation.

MARKET-READY

Product, IP & Regulatory

MokaDex outputs can support product direction, IP assessment, regulatory review, and formulation decisions.

Moka Targets

Same technology,
different products and business models

Our primary focus is to refine MokaDex in less regulated and fast-commercializing environments. We are building the evidence needed for future expansions.

Today we are targeting the nutraceutical industry. Tomorrow we will scale through cosmetics, functional ingredients, and beyond.

NOW

Nutraceuticals & Cosmetics

▸ Discovery of novel bioactive molecules
▸ Direct formulation services & SaaS
▸ High-value Intellectual Property (IP) Assets

▸ R&D for novel drug candidates
▸ Licensing & Co-development contracts
▸ Complex molecular pattern analysis (AI)